{"title":"Norplant as a contraceptive device in Enugu, eastern Nigeria.","authors":"B Ozumba, W Chukudebelu, R Snow","doi":"10.1023/a:1006586616653","DOIUrl":null,"url":null,"abstract":"<p><p>This paper is an evaluation of acceptability and use-experience with the contraceptive device Norplant at the University of Nigeria Teaching Hospital, Enugu, Eastern Nigeria. Over a period of 36 months, 173 women (8% of the clinic population) accepted the implant. Use of Norplant was concentrated among high-parity women, and the proportion of Norplant users was highest among women aged 30-34 years. Comparing Norplant and IUD users, we found Norplant users to be significantly less highly educated with < 1% of Norplant users having tertiary education compared to 25% of new IUD users. The continuation rate with Norplant was 89% at three years, suggesting this method has the potential for improving the low contraceptive prevalence in this region.</p>","PeriodicalId":76977,"journal":{"name":"Advances in contraception : the official journal of the Society for the Advancement of Contraception","volume":"14 2","pages":"109-19"},"PeriodicalIF":0.0000,"publicationDate":"1998-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1023/a:1006586616653","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in contraception : the official journal of the Society for the Advancement of Contraception","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1023/a:1006586616653","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8
Abstract
This paper is an evaluation of acceptability and use-experience with the contraceptive device Norplant at the University of Nigeria Teaching Hospital, Enugu, Eastern Nigeria. Over a period of 36 months, 173 women (8% of the clinic population) accepted the implant. Use of Norplant was concentrated among high-parity women, and the proportion of Norplant users was highest among women aged 30-34 years. Comparing Norplant and IUD users, we found Norplant users to be significantly less highly educated with < 1% of Norplant users having tertiary education compared to 25% of new IUD users. The continuation rate with Norplant was 89% at three years, suggesting this method has the potential for improving the low contraceptive prevalence in this region.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
